Selected presentations from the 5th Congress of The International Society for the Study of The Aging Male held in Salzburg February 9-12, 2006 are now available:
Keynote Lectures
Ridwan Shabsigh, United States
Kevin Channer, United Kingdom
Symposiums
- Epidemiology - Testosterone and the metabolic syndrome
- Is there a role for testosterone in type II diabetes mellitus?
- Pathogenesis of the metabolic syndrome: the interplay between obesity and androgens
- An endocrine approach to address the cluster of risk factors associated with development of type II diabetes in men
- Long term experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido®) in substitution therapy of hypogonadal men
- Monitoring the safety and efficacy of intramuscular testosterone undecanoate in elderly hypogonadal men
- Comparison of kinetics, efficacy and safety of the long-acting testosterone undecanoate formulation with standard testosterone enanthate
- Long-acting testosterone ester injection as a second line therapy in hypogonadal patients with erectile dysfunction
- How to select the right patient?
- Which patients with sexual dysfunction are suitable for testosterone replacement therapy?
- TRT - Who is benefiting and who is at risk?
- Metabolic syndrome and sexual dysfunction
- Androgen deficiency and hormone replacement therapy
- Regulation of penile erection by androgen-dependent cellular and molecular mechanism
- Testosterone and his brain
- Testosterone and his body functions
- His mind, his body, his spirit, his testosterone therapy: testosterone & his erectile physiology
- Testosterone and his quality of life
Copyright © 2006 ISSAM